Scitech Specialties News Today

Read more about Advanced Enzyme Q4 PAT rises 3% YoY to Rs 34 cr on Business Standard. On a consolidated basis, Advanced Enzyme Technologies posted 3.4% rise in net profit to Rs 33.8 crore on 20.8% rise in net sales to Rs 133.22 crore in Q4 FY21 over Q4 FY20.

Advanced Enzyme Technologies rose 1.63% to Rs 330.40 after the company said its board on 26 December 2020 approved investments of Rs 31.62 crore in SciTech Specialties for a 51% stake.Advanced Enzyme will subscribe 4,92,630 equity shares of SciTech Specialties (SSPL) via preferential issue and purchase 27,778 from selling shareholders of SSPL, aggregating to 5,20,408 shares. SSPL is a contract manufacturing company with niche technology specialising in effervescent granules and tablets. It is f...

The Board of Advanced Enzyme Technologies in its meeting held on 26 December 2020 has approved the (a) investment of an amount not exceeding Rs. 31.62 crore by way of subscription to the issue of 492,630 equity shares of SciTech Specialties (SSPL) as may be offered on preferential issue / private placement basis by SSPL and purchase of 27,778 from selling shareholders of SSPL, aggregating to 520,408 equity shares i.e. 51% of equity share capital of SSPL, and (b) authorization for signing of Sha...